Location History:
- Littleton, MA (US) (1990)
- Shirley, MA (US) (1991 - 1998)
Company Filing History:
Years Active: 1990-1998
Title: The Innovative Contributions of Robert E. Donahue
Introduction
Robert E. Donahue, an accomplished inventor based in Shirley, MA, has made significant contributions to the field of biotechnology. With a total of five patents to his name, his work primarily focuses on groundbreaking innovations related to human cytokines and growth factors. His inventions have the potential to impact medical science and therapies involving erythropoiesis.
Latest Patents
Among his latest inventions, Donahue has developed DNA encoding the human cytokine interleukin-9. This particular invention offers a novel human erythropoietic growth factor, with processes designed for producing it via recombinant DNA genetic engineering techniques. Another notable patent from Donahue involves DNA molecules that encode a human protein of 144 amino acids, referred to as interleukin-9 or IL-9. This protein serves as an erythropoietic growth factor, and the patent includes processes for producing the IL-9 protein through advanced genetic engineering techniques.
Career Highlights
Throughout his career, Robert E. Donahue has worked with prominent companies in the field of biotechnology. Notable among them is the Genetics Institute, Inc., where he contributed to cutting-edge research and development. Additionally, he was associated with the Ludwig Institute for Cancer Research Limited, further showcasing his commitment to advancing scientific knowledge and patient care.
Collaborations
Collaboration has played a significant role in Donahue's career. He has worked alongside talented professionals such as Steven C. Clark and Agnes B. Ciarletta. These collaborations have undoubtedly enriched his innovative pursuits and expanded the reach and impact of his inventions.
Conclusion
Robert E. Donahue stands as a notable figure in the area of biotechnology, with his patents and collaborative endeavors underscoring his influential role in the scientific community. His innovative work on interleukin-9 and related growth factors not only exemplifies his ingenuity but also holds promise for future advancements in medical treatments.